News

From left to right: Ursula Weyrich, Administrative Director of the DKFZ; awardee Ute Mons; Michael Baumann, Chairman and Scientific Director of the DKFZ; Catharina Seegelken, Managing Director of the Manfred Lautenschläger Foundation; awardee Carolin Schneider; Rudolf Kaaks and Mathias Heikenwälder, the two presenters of the laudations.

Third German Award for Research in Cancer Prevention honors outstanding scientists

_27/05/2025
Cancer prevention can save lives and alleviate suffering. Yet, research in this field often remains underrepresented. To recognize outstanding achievements in cancer prevention research, the German Cancer Research Center (DKFZ) established the German Award for Research in Cancer Prevention, funded by the Manfred Lautenschläger Foundation. The award was presented at the 4th German Cancer Research Congress. The main prize was awarded to Ute Mons from the DKFZ, who was the first in Germany to estimate how many cancer cases are linked to modifiable risk factors. The early-career researcher award went to Carolin Schneider from University Hospital Aachen, who is exploring how artificial intelligence can use global health data to generate recommendations for cancer prevention.

Read more at dkfz.de

Explainable artificial intelligence increases the accuracy and endurance of dermatologists in melanoma diagnosis

05/26/2025 | by Koh

Scientists at the German Cancer Research Center (DKFZ) have shown in an international eye-tracking study that dermatologists not only improve their diagnostic accuracy by using explainable artificial intelligence, but also show significantly less fatigue when assessing challenging cases. The researchers were able to demonstrate this by measuring a reduction in cognitive stress indicators.

Read more at dkfz.de

New approach for T-cell immunotherapy against malignant brain tumors

03/17/2025 | by Koh

Researchers at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) have developed a promising cellular immunotherapy for the treatment of glioblastomas: They equipped T cells with a receptor that recognizes a protein of the brain tumors that is responsible for the dangerous stem cell properties. The therapeutic T cells directed against this target structure were able to specifically destroy human brain tumors in laboratory experiments and in mice.

Read more at dkfz.de

DKFZ Hector Cancer Institute at University Medicine Mannheim receives further substantial support from Hector Foundation

02/27/2025 | by Koh

After receiving an excellent rating in its first international evaluation, the Hector Foundation II has once again generously increased its funding for the DKFZ Hector Cancer Institute. The new funds will support the further development of the two central research areas: precision oncology as well as prevention, early detection, and survivorship. The DKFZ Hector Cancer Institute at University Medicine Mannheim is a joint initiative of the German Cancer Research Center (DKFZ), the Medical Faculty Mannheim of Heidelberg University, and the University Medical Center Mannheim.

Read more at dkfz.de